Patients screened had type 2 diabetes were treated with basal insulin for at least 6 months, receiving a stable daily dose of between 15 and 40 units alone or combined with 1 or 2 OADs (metformin, sulfonylurea, glinide, SGLT-2 inhibitor or a DPP-4 inhibitor), had an HbA1c between 7.5% and 10% and a FPG less than or equal to 180 mg/dL or 200 mg/dL depending on their previous antidiabetic treatment
These practical considerations often prove decisive in real-world decision making
Yes, Hers and Hims offers brand-name medications like Ozempic, Wegovy, Mounjaro, and Zepbound
Currently, the approved GLP-1 agonists in the UK mimic GLP-1 (Wegovy and liraglutide), or both GLP-1 and GIP (Mounjaro)
This irregularity often occurs during the initial months of treatment as the body adjusts to metabolic changes
These are single, non-systematic captures from Jun 21, 2026 (Gemini), illustrative of what assistants say, not a ranking